Updates are available Correction dated 2024-01-03
Click to view Correction: https://doi.org/10.1038/s41586-023-06942-4
-
Authors
Devant, Pascal
Dong, Ying
Mintseris, Julian
Ma, Weiyi https://orcid.org/0009-0002-2290-8725
Gygi, Steven P. https://orcid.org/0000-0001-7626-0034
Wu, Hao https://orcid.org/0000-0002-7281-8579
Kagan, Jonathan C. https://orcid.org/0000-0003-2364-2746
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 16 October 2023
First Online: 22 November 2023
Change Date: 3 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-023-06942-4
Competing interests
: J.C.K. consults and holds equity in Corner Therapeutics, Larkspur Biosciences and Neumora Therapeutics. H.W. is a co-founder and chair of the scientific advisory board of Ventus Therapeutics. None of these relationships influenced this study. The other authors declare no competing interests.
